Our researchers bring hundreds of years of experience from industry, regulatory authorities, and academia in all important therapeutic areas, as well as advanced degrees in medicine, pharmacoepidemiology, biostatistics, pharmacology, and public health to the table to provide expert advice on all areas of pharmacovigilance risk management and pharmacoepidemiology.

We can support you in specific short term projects or through extended arrangements with dedicated experts on a long term basis, as well as help you and your teams address training needs. Our experts have been providing trainings on signal and benefit-risk management or pharmacoepidemiology for the DIA, regulatory authorities, and companies, as well as having been engaged in the teaching of advanced courses at the Biocenter Basel and other academic institutions.